SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-May-24 4:06 PM View: | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 14% 23.39K to 26.59K | |
29-Mar-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Mar-24 | Option Exercise | 3,278 | $3.74 | $12,259.70 | 14% 23.39K to 26.67K | |
29-Mar-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Mar-24 | Option Sale | 3,278 | $51.57 | $169,046.00 | (12%) 26.67K to 23.39K | |
22-Feb-24 4:07 PM View: | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Option Exercise | 722 | $3.74 | $2,700.28 | 3% 23.39K to 24.12K | |
22-Feb-24 4:07 PM View: | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Option Sale | 722 | $50.01 | $36,107.20 | (3%) 24.12K to 23.39K | |
30-Jan-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 29-Jan-24 | Private Sale | 2,300 | $44.22 | $101,706.00 | (9%) 25.7K to 23.39K | |
29-Jan-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 25-Jan-24 | Private Sale | 200 | $44.02 | $8,804.00 | (< 1%) 25.89K to 25.7K | |
24-Jan-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 22-Jan-24 | Option Exercise | 3,000 | $4.12 | $12,360.00 | 10% 30.89K to 33.9K | |
24-Jan-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 22-Jan-24 | Option Sale | 3,000 | $41.85 | $125,541.00 | (9%) 33.9K to 30.89K | |
24-Jan-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 22-Jan-24 | Sale | 5,000 | $41.85 | $209,234.00 | (16%) 30.89K to 25.89K | |
16-Jan-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 12-Jan-24 | Market Sale | 2,200 | $38.09 | $83,798.00 | (7%) 33.09K to 30.89K | (2%) |
17-Nov-23 4:06 PM View: | Aastrom Biosciences, Inc. (VCEL) | 15-Nov-23 | Market Sale | 300 | $38.02 | $11,406.00 | (< 1%) 33.4K to 33.09K | (2%) |
17-Jul-23 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 14-Jul-23 | Market Sale | 1,000 | $38.84 | $38,840.00 | (3%) 34.4K to 33.4K | (< 1%) |
26-Jun-23 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 22-Jun-23 | Market Sale | 3,000 | $36.00 | $108,000.00 | (8%) 37.4K to 34.4K | (8%) |
28-Apr-23 4:04 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Apr-23 | Option Exercise | 2,600 | -- | -- | 7% 34.8K to 37.4K | |
03-Mar-23 4:32 PM View: | Aastrom Biosciences, Inc. (VCEL) | 01-Mar-23 | Option Exercise | 3,000 | $10.60 | $31,800.00 | 9% 31.8K to 34.8K | |
29-Apr-22 4:18 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Apr-22 | Option Exercise | 2,600 | -- | -- | 149% 1.75K to 4.35K | |
30-Apr-21 4:06 PM View: | Aastrom Biosciences, Inc. (VCEL) | 28-Apr-21 | Option Exercise | 1,750 | -- | -- | 100% 0 to 1.75K | |
24-Nov-20 4:09 PM View: | Aastrom Biosciences, Inc. (VCEL) | 23-Nov-20 | Option Exercise | 30,000 | $3.25 | $97,500.00 | 155% 19.3K to 49.3K | |
24-Nov-20 4:09 PM View: | Aastrom Biosciences, Inc. (VCEL) | 23-Nov-20 | Market Option Sale | 17,500 | $23.55 | $412,125.00 | (36%) 49.3K to 31.8K | (23%) |
01-May-20 4:17 PM View: | Aastrom Biosciences, Inc. (VCEL) | 29-Apr-20 | Option Exercise | 1,750 | -- | -- | 10% 17.55K to 19.3K | |
24-Jan-19 4:03 PM View: | Aastrom Biosciences, Inc. (VCEL) | 22-Jan-19 | Option Exercise | 17,500 | $2.63 | $46,025.00 | 38889% 45 to 17.55K | |
28-Oct-13 3:22 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 15,000 | $10.75 | $161,250.00 | (100%) 15.0K to 0 | |
03-Jan-13 4:30 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 01-Jan-13 | Grant | 7,500 | -- | -- | 100% 7.5K to 15.0K | |
25-Jun-12 4:57 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 31-May-12 | Grant | 2,500 | -- | -- | 50% 5.0K to 7.5K | |
03-Jan-12 7:50 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 01-Jan-12 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
26-May-10 1:56 PM View: | AP Pharma Inc. (HRTX) | 20-May-10 | Grant | 95,891 | -- | -- | 90% 106.18K to 202.07K | |
19-Feb-10 1:25 PM View: | AP Pharma Inc. (HRTX) | 17-Feb-10 | Grant | 14,042 | -- | -- | 15% 92.14K to 106.18K | |
29-May-09 9:31 PM View: | AP Pharma Inc. (HRTX) | 27-May-09 | Grant | 70,000 | -- | -- | 316% 22.14K to 92.14K | |
30-May-08 7:26 PM View: | AP Pharma Inc. (HRTX) | 28-May-08 | Grant | 9,000 | $0.01 | $90.00 | 34% 26.28K to 35.28K | 15600% |
25-May-07 12:34 PM View: | AP Pharma Inc. (HRTX) | 23-May-07 | Grant | 12,000 | $0.01 | $120.00 | 30% 40.56K to 52.56K | |
14-Aug-06 2:40 PM View: | AP Pharma Inc. (HRTX) | 11-Aug-06 | Grant | 1,714 | $1.75 | $2,999.50 | 4% 38.84K to 40.56K | |
01-Jun-06 10:00 PM View: | AP Pharma Inc. (HRTX) | 31-May-06 | Grant | 5,000 | -- | -- | 15% 33.84K to 38.84K | |
15-May-06 5:21 PM View: | AP Pharma Inc. (HRTX) | 15-May-06 | Grant | 2,000 | $2.00 | $4,000.00 | 6% 31.84K to 33.84K | |
20-Mar-06 5:00 PM View: | AP Pharma Inc. (HRTX) | 20-Mar-06 | Grant | 2,614 | $1.53 | $3,999.42 | 9% 29.23K to 31.84K | |
19-Jan-06 4:47 PM View: | Aastrom Biosciences, Inc. (VCEL) | 16-Jan-06 | Grant | 7,200 | -- | -- | 100% 0 to 7.2K | |
07-Nov-05 6:41 PM View: | AP Pharma Inc. (HRTX) | 07-Nov-05 | Grant | 2,299 | $1.74 | $4,000.26 | 9% 26.93K to 29.23K | (79%) |
11-Aug-05 5:57 PM View: | AP Pharma Inc. (HRTX) | 11-Aug-05 | Grant | 2,400 | $1.66 | $3,984.00 | 10% 24.53K to 26.93K | (78%) |
12-May-05 5:21 PM View: | AP Pharma Inc. (HRTX) | 12-May-05 | Grant | 3,472 | $1.44 | $4,999.68 | 16% 21.06K to 24.53K | |
15-Mar-05 5:23 PM View: | AP Pharma Inc. (HRTX) | 15-Mar-05 | Grant | 2,424 | $1.65 | $3,999.60 | 13% 18.64K to 21.06K | (78%) |
17-Nov-04 3:09 PM View: | AP Pharma Inc. (HRTX) | 17-Nov-04 | Grant | 3,704 | $1.35 | $5,000.40 | 25% 14.93K to 18.64K | (73%) |
02-Sep-04 7:02 PM View: | AP Pharma Inc. (HRTX) | 02-Sep-04 | Grant | 1,194 | $3.35 | $3,999.90 | 9% 13.74K to 14.93K | |
12-May-04 10:00 PM View: | AP Pharma Inc. (HRTX) | 12-May-04 | Grant | 2,834 | $2.82 | $8,000.18 | 26% 10.9K to 13.74K | |
20-Nov-03 10:00 PM View: | AP Pharma Inc. (HRTX) | 19-Nov-03 | Grant | 1,794 | $2.23 | $4,000.62 | 20% 9.11K to 10.9K | (84%) |